Agoracom Blog Home

Posts Tagged ‘Medical Marjuana Stocks’

North Bud Farms Inc. $ – As marijuana firms flourish, Canadian exchange will hold lottery for the stock ticker POT $ACB $ $

Posted by AGORACOM-JC at 9:55 AM on Wednesday, January 30th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information



As marijuana firms flourish, Canadian exchange will hold lottery for the stock ticker POT


POT, previously the ticker for Potash Corp. of Saskatchewan before it merged with Agrium to form Nutrien, becomes available for use Feb. 1, 2019. (Richard Vogel/AP) Kristine OwramBloomberg NewsPrivacy Policy

The stock symbol POT is up for grabs on Canadian exchanges, and demand is so high that a lottery is being held for the first time ever to determine who gets it.

POT, previously the ticker for Potash Corp. of Saskatchewan before it merged with Agrium to form Nutrien, becomes available for use Friday. Not surprisingly, the cannabis-themed symbol has attracted “significant interest,” according to a staff notice published by the Toronto Stock Exchange.

Applications from companies are due by 5 p.m. Tuesday in Toronto, and a random lottery will be held Wednesday to determine the winner. TMX Group spokeswoman Catherine Kee declined to comment on how many applications it’s gotten, or how many of the interested companies are related to the fast-growing cannabis sector.

Canada now world's largest legal marijuana marketplace

POT isn’t the only marijuana-themed ticker symbol out there. Canopy Growth Corp., the world’s biggest cannabis company by market value, trades under the symbol WEED in Canada and the ETFMG Alternative Harvest exchange-traded fund uses the symbol MJ, short for Mary Jane. Other creative symbols used by cannabis firms include TGIF, which belongs to 1933 Industries Inc., and FSD Pharma’s HUGE.

The POT lottery is open to companies listed on any Canadian exchange, including the TSX, TSX Venture Exchange, Canadian Securities Exchange and Aequitas NEO Exchange. Exchange-traded funds and issuers without an active operating business aren’t eligible to participate.

With assistance from Bloomberg’s Brad Olesen.

Follow @ChiTribBusiness on Facebook and @ChiTribBiz on Twitter.


Lexaria Oilfield Sale Completed

Posted by AGORACOM-JC at 8:10 AM on Wednesday, December 10th, 2014

KELOWNA, BC / December 10, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce the sale of all its Belmont Lake oil assets for $1.4 million in cash has closed and all money received. Lexaria congratulates the new owners for having purchased a fine asset.

Lexaria has now repaid all outstanding debts. As a result our monthly expenditures have decreased and we are no longer making interest or principal repayments.

“We are very excited about using our new cash reserves to launch PoViva Tea and pursue our alternative-health business plan,” said Chris Bunka, CEO of Lexaria.

Lexaria is working almost around-the-clock to be able to offer PoViva tea to consumers as quickly as possible. We are hoping to be able to announce our ability to accept pre-orders before Christmas.

We are close to unveiling our new 1st generation PoViva website with an announcement pending in the days to come.

Lexaria is asking all its shareholders to spread the word of PoViva Tea and our patent pending process of delivering CBD, in preparation for sales to commence. We also remind all concerned that the CBD-oil derived from agricultural hemp that PoViva uses is legal in all 50 states and never contains more than inconsequential amounts of THC; less than 0.3%.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit


Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424


This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.